Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Author: Benzinga Insights | March 26, 2024 09:05am

Gainers

  • Stoke Therapeutics (NASDAQ:STOK) stock increased by 80.2% to $11.71 during Tuesday's pre-market session. The market value of their outstanding shares is at $522.8 million. As per the press release, Q4 earnings came out yesterday.
  • OpGen (NASDAQ:OPGN) shares moved upwards by 77.6% to $0.84. The market value of their outstanding shares is at $8.4 million.
  • ABVC BioPharma (NASDAQ:ABVC) stock increased by 45.71% to $1.53. The market value of their outstanding shares is at $16.1 million.
  • Mesoblast (NASDAQ:MESO) shares moved upwards by 32.27% to $2.91. The market value of their outstanding shares is at $295.3 million.
  • Praxis Precision Medicine (NASDAQ:PRAX) shares increased by 21.38% to $61.3. The market value of their outstanding shares is at $811.5 million.
  • Sutro Biopharma (NASDAQ:STRO) stock moved upwards by 18.96% to $3.89. The company's market cap stands at $237.1 million. The company's, Q4 earnings came out yesterday.

Losers

  • NeuBase Therapeutics (NASDAQ:NBSE) stock decreased by 55.0% to $0.45 during Tuesday's pre-market session. The company's market cap stands at $1.6 million.
  • Tivic Health Systems (NASDAQ:TIVC) shares fell 14.49% to $1.24. The company's market cap stands at $1.8 million. The company's, Q4 earnings came out yesterday.
  • bluebird bio (NASDAQ:BLUE) shares fell 12.51% to $1.19. The company's market cap stands at $229.3 million. As per the press release, Q4 earnings came out today.
  • BioLine Rx (NASDAQ:BLRX) stock declined by 11.54% to $1.15. The market value of their outstanding shares is at $83.3 million. The company's, Q4 earnings came out today.
  • iSpecimen (NASDAQ:ISPC) stock fell 8.48% to $0.23. The market value of their outstanding shares is at $2.0 million.
  • IMAC Hldgs (NASDAQ:BACK) stock decreased by 8.27% to $2.22. The company's market cap stands at $2.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ABVC BACK BLRX BLUE ISPC MESO NBSE OPGN PRAX STOK STRO TIVC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist